适应性富集设计中对数据驱动亚组的疗效评估
针对自适应富集设计(AED)中亚组选择后缺乏疗效估计与检验程序的问题,本文提出一种两阶段AED,要求预先指定基于基线协变量选择亚组的算法,并利用交叉验证与自助法校正重代入偏倚。通过模拟人类免疫缺陷病毒感染的临床试验对方法进行了评价与比较。
要点
- 提出两阶段自适应富集设计,不要求预先定义亚组,但需预先指定亚组选择算法。
- 利用交叉验证与自助法校正所选亚组疗效估计中的重代入偏倚。
- 通过模拟人类免疫缺陷病毒感染临床试验评价并比较了所提方法。
核心结论
- 提出的两阶段自适应富集设计可在不预先定义亚组的情况下选择亚组,并利用交叉验证与自助法校正疗效估计的重代入偏倚。
研究设计与样本
- 提出一种两阶段自适应富集设计,不要求预先定义亚组,但要求预先指定基于基线协变量信息选择亚组的算法。
主要发现
- 通过模拟人类免疫缺陷病毒感染的实际临床试验,对所提方法进行了评价与比较。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Adaptive enrichment designs (AEDs) of clinical trials allow investigators to restrict enrollment to a promising subgroup based on an interim analysis. Most of the existing AEDs deal with a small number of predefined subgroups, which are often unknown at the design stage. The newly developed Simon design offers a great deal of flexibility in subgroup selection (without requiring pre-defined subgroups) but does not provide a procedure for estimating and testing treatment efficacy for the selected subgroup. This article proposes a 2-stage AED which does not require predefined subgroups but requires a prespecified algorithm for choosing a subgroup on the basis of baseline covariate information. Having a prespecified algorithm for subgroup selection makes it possible to use cross-validation and bootstrap methods to correct for the resubstitution bias in estimating treatment efficacy for the selected subgroup. The methods are evaluated and compared in a simulation study mimicking actual clinical trials of human immunodeficiency virus infection.
引用
- Zhang Z, Chen R, Soon G, et al. Treatment evaluation for a data-driven subgroup in adaptive enrichment designs of clinical trials. Stat Med. 2017. PMID: 28948633. doi:10.1002/sim.7497
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。